09/07/2026
When Gynaecological Oncology meets Obstetrics and Gynaecologyđ¤.
Very rarely do I get the opportunity to fulfil my dual roles in the same patient. But recently, I could do so to satisfactory outcome.
This young 25 yr old nulliparous lady, first came to me in Aug 2022 with a large complex 16cm ovarian cystic mass, recurrence after a laparoscopic ovarian cystectomy outside. The mass had solid areas, with suspicion of malignancy and high CA125,and was referred timely to me. On CECT chest+abdomen there was no distant metastasis. A fertility sparing cytoreductive surgery was done by me(RSO+RPLND+omentectomy+
appendicectomy & peritonectomy) after intra op imprinting was suggestive of malignant neoplasm. Final histology was stage 1C2(pT1C2 N0 M0 mucinous Rt ovarian cystadenocarcinoma with expansile and infiltrative components). Current guidelines only suggest fertility sparing for stage 1C expansile ovarian mucinous cystadenocarcinoma, so we had to go against existing evidence, to tailor care as per her wishes.
Understandably, the family was crestfallen. She underwent adjuvant 6 cycles chemotherapy. Her eggs were frozen beforehand. She did try IVF 2 cycles a year later to no avail. But we didnot give up.
In late 2025, she conceived under my care by herself. After 38 weeks of caution, trepidation and quiet optimism, she delivered by a slightly difficult LSCS, a healthy 3200grams boy baby in June 2026. Mother and baby are doing well now.
This case study highlights personalised care for women with ovarian cancer, fertility sparing options and need for care and supervision by a Gynae Oncologist led team.
Our society is trained to think that life ends after cancer diagnosis and to give up all hope. For her, her second life began after the diagnosis, following timely diagnosis, referral and treatment and listening to doctors instructions and following them well.
āϝāĻāύ āĻāĻžāĻāύā§āĻā§āϞāĻāĻŋāĻā§āϝāĻžāϞ āĻ
āύāĻā§āϞāĻāĻŋ (āϏā§āϤā§āϰā§āϰā§āĻ-āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻāĻŋāĻāĻŋā§āϏāĻž) āĻāĻŦāĻ āĻ
āĻŦāϏā§āĻā§āĻā§āϰāĻŋāĻā§āϏ āĻ āĻāĻžāĻāύā§āĻā§āϞāĻāĻŋ (āĻĒā§āϰāϏā§āϤāĻŋ āĻ āϏā§āϤā§āϰā§āϰā§āĻāĻŦāĻŋāĻĻā§āϝāĻž) āĻāĻā§ āĻ
āĻĒāϰā§āϰ āĻĒāϰāĻŋāĻĒā§āϰāĻ āĻšā§ā§ āĻāĻ ā§ đ¤āĨ¤
āĻāĻāĻ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻāĻŽāĻžāϰ āĻĻā§āĻŦā§āϤ āĻā§āĻŽāĻŋāĻāĻž (āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻŦāĻŋāĻļā§āώāĻā§āĻ āĻ āĻĒā§āϰāϏā§āϤāĻŋ-āϏā§āϤā§āϰā§āϰā§āĻ āĻŦāĻŋāĻļā§āώāĻā§āĻ āĻšāĻŋāϏā§āĻŦā§) āĻĒāĻžāϞāύ āĻāϰāĻžāϰ āϏā§āϝā§āĻ āĻā§āĻŦ āĻāĻŽāĻ āĻāϏā§āĨ¤ āϤāĻŦā§ āϏāĻŽā§āĻĒā§āϰāϤāĻŋ āĻāĻŽāĻŋ āϏāĻĢāϞāĻāĻžāĻŦā§ āϏā§āĻ āĻāĻžāĻāĻāĻŋ āĻāϰāϤ⧠āĻĒā§āϰā§āĻāĻŋāĨ¤
⧍ā§Ģ āĻŦāĻāϰ āĻŦā§āϏ⧠āĻāĻ āϤāϰā§āĻŖā§, āϝāĻŋāύāĻŋ āĻāĻā§ āĻāĻāύāĻ āϏāύā§āϤāĻžāύ āϧāĻžāϰāĻŖ āĻāϰā§āύāύāĻŋ, ⧍ā§Ļ⧍⧍ āϏāĻžāϞā§āϰ āĻāĻāϏā§āĻ āĻŽāĻžāϏ⧠āĻāĻŽāĻžāϰ āĻāĻžāĻā§ āĻāϏā§āύāĨ¤ āϤāĻžāĻāϰ āĻĄāĻŋāĻŽā§āĻŦāĻžāĻļā§ā§ ā§§ā§Ŧ āϏā§āύā§āĻāĻŋāĻŽāĻŋāĻāĻžāϰā§āϰ āĻāĻāĻāĻŋ āĻŦā§ āĻ āĻāĻāĻŋāϞ āϏāĻŋāϏā§āĻ āĻŦāĻž āĻāĻŋāĻāĻŽāĻžāϰ āĻāĻŋāϞ; āĻāϰ āĻāĻā§ āĻ
āύā§āϝ āĻā§āĻĨāĻžāĻ āϞā§āϝāĻžāĻĒāĻžāϰā§āϏā§āĻā§āĻĒāĻŋāĻ āĻĒāĻĻā§āϧāϤāĻŋāϤ⧠āϏāĻŋāϏā§āĻāĻāĻŋ āĻ
āĻĒāϏāĻžāϰāĻŖ āĻāϰāĻž āĻšāϞā§āĻ āϤāĻž āĻĒā§āύāϰāĻžā§ āĻĻā§āĻāĻž āĻĻāĻŋā§ā§āĻāĻŋāϞāĨ¤ āĻāĻŋāĻāĻŽāĻžāϰāĻāĻŋāϤ⧠āĻāĻ āĻŋāύ āĻ
āĻāĻļā§āϰ (solid areas) āĻāĻĒāϏā§āĻĨāĻŋāϤāĻŋ āĻāĻŦāĻ āĻāĻā§āĻ CA125 āĻŽāĻžāϤā§āϰāĻžāϰ āĻāĻžāϰāĻŖā§ āĻŽā§āϝāĻžāϞāĻŋāĻāύā§āϝāĻžāύā§āϏāĻŋ āĻŦāĻž āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āϏāύā§āĻĻā§āĻš āĻāϰāĻž āĻšā§ āĻāĻŦāĻ āϤāĻžāĻāĻā§ āϏāĻŽā§āĻŽāϤ⧠āĻāĻŽāĻžāϰ āĻāĻžāĻā§ āϰā§āĻĢāĻžāϰ āĻāϰāĻž āĻšā§āĨ¤ āĻŦā§āĻā§āϰ āĻ āĻĒā§āĻā§āϰ CECT āϏā§āĻā§āϝāĻžāύ⧠āĻļāϰā§āϰā§āϰ āĻ
āύā§āϝ āĻā§āĻĨāĻžāĻ āĻā§āϝāĻžāύā§āϏāĻžāϰ āĻā§āĻŋā§ā§ āĻĒā§āĻžāϰ (distant metastasis) āĻā§āύ⧠āϞāĻā§āώāĻŖ āĻĒāĻžāĻā§āĻž āϝāĻžā§āύāĻŋāĨ¤ āĻ
āϏā§āϤā§āϰā§āĻĒāĻāĻžāϰā§āϰ āϏāĻŽā§ āύā§āĻā§āĻž āύāĻŽā§āύāĻžā§ āĻŽā§āϝāĻžāϞāĻŋāĻāύā§āϝāĻžāύā§āĻ āύāĻŋāĻāĻĒā§āϞāĻžāĻāĻŽ āĻŦāĻž āĻā§āϝāĻžāύā§āϏāĻžāϰā§āϰ āĻāĻā§āĻāĻŋāϤ āĻĒāĻžāĻā§āĻžā§ āĻāĻŽāĻŋ 'āĻĢāĻžāϰā§āĻāĻŋāϞāĻŋāĻāĻŋ āϏā§āĻĒā§āϝāĻŧāĻžāϰāĻŋāĻ āϏāĻžāĻāĻā§āϰāĻŋāĻĄāĻžāĻā§āĻāĻŋāĻ āϏāĻžāϰā§āĻāĻžāϰāĻŋ' (āĻ
āϰā§āĻĨāĻžā§ āĻĒā§āϰāĻāύāύ āĻā§āώāĻŽāϤāĻž āĻ
āĻā§āώā§āĻŖā§āĻŖ āϰā§āĻā§ āĻāĻŋāĻāĻŽāĻžāϰ āĻ
āĻĒāϏāĻžāϰāĻŖā§āϰ āĻ
āϏā§āϤā§āϰā§āĻĒāĻāĻžāϰ) āĻāϰāĻŋ; āϝāĻžāϰ āĻŽāϧā§āϝ⧠āĻāĻŋāϞ āĻĄāĻžāύ āĻĻāĻŋāĻā§āϰ āĻĄāĻŋāĻŽā§āĻŦāĻžāĻļā§ āĻ
āĻĒāϏāĻžāϰāĻŖ (RSO), āϞāĻŋāĻŽā§āĻĢ āύā§āĻĄ āĻ
āĻĒāϏāĻžāϰāĻŖ (RPLND), āĻāĻŽā§āύā§āĻā§āĻā§āĻāĻŽāĻŋ, āĻ
ā§āϝāĻžāĻĒā§āύā§āĻĄāĻŋāĻā§āĻāĻŽāĻŋ āĻāĻŦāĻ āĻĒā§āϰāĻŋāĻā§āύāĻŋāĻā§āĻāĻŽāĻŋāĨ¤ āĻā§ā§āĻžāύā§āϤ āĻšāĻŋāϏā§āĻā§āϞāĻāĻŋ āϰāĻŋāĻĒā§āϰā§āĻā§ 'āϏā§āĻā§āĻ 1C2' (pT1C2 N0 M0 āĻŽāĻŋāĻāϏāĻŋāύāĻžāϏ āϰāĻžāĻāĻ āĻāĻāĻžāϰāĻŋā§āĻžāύ āϏāĻŋāϏā§āĻāĻ
ā§āϝāĻžāĻĄāĻŋāύā§āĻāĻžāϰā§āϏāĻŋāύā§āĻŽāĻžâāϝāĻžāϤ⧠āĻāĻā§āϏāĻĒā§āϝāĻžāύāϏāĻžāĻāϞ āĻ āĻāύāĻĢāĻŋāϞāĻā§āϰā§āĻāĻŋāĻ āĻāĻĒāĻžāĻĻāĻžāύ āĻāĻŋāϞ) āϧāϰāĻž āĻĒā§ā§āĨ¤ āĻŦāϰā§āϤāĻŽāĻžāύ āύāĻŋāϰā§āĻĻā§āĻļāĻŋāĻāĻž āĻ
āύā§āϝāĻžā§ā§ āĻļā§āϧā§āĻŽāĻžāϤā§āϰ 'āϏā§āĻā§āĻ 1C āĻāĻā§āϏāĻĒā§āϝāĻžāύāϏāĻžāĻāϞ āĻāĻāĻžāϰāĻŋā§āĻžāύ āĻŽāĻŋāĻāϏāĻŋāύāĻžāϏ āϏāĻŋāϏā§āĻāĻ
ā§āϝāĻžāĻĄāĻŋāύā§āĻāĻžāϰā§āϏāĻŋāύā§āĻŽāĻž'-āϰ āĻā§āώā§āϤā§āϰā§āĻ āĻĒā§āϰāĻāύāύ āĻā§āώāĻŽāϤāĻž āϰāĻā§āώāĻžāϰ āĻŦāĻŋāώā§āĻāĻŋ āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻšā§; āϤāĻžāĻ āϰā§āĻā§āϰ āĻāĻā§āĻāĻžāύā§āϝāĻžāϝāĻŧā§ āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒāĻĻā§āϧāϤāĻŋ āĻ āĻŋāĻ āĻāϰāϤ⧠āĻāĻŽāĻžāĻĻā§āϰ āĻĒā§āϰāĻāϞāĻŋāϤ āύāĻŋāϰā§āĻĻā§āĻļāĻŋāĻāĻžāϰ āĻŦāĻžāĻāϰ⧠āĻāĻŋā§ā§ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āύāĻŋāϤ⧠āĻšā§ā§āĻāĻŋāϞāĨ¤
āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻāĻāĻžāĻŦā§āĻ, āϤāĻžāĻāϰ āĻĒāϰāĻŋāĻŦāĻžāϰ āĻŽāĻžāύāϏāĻŋāĻāĻāĻžāĻŦā§ āĻā§āĻā§ āĻĒā§ā§āĻāĻŋāϞāĨ¤ āĻāϰāĻĒāϰ āϤāĻŋāύāĻŋ ā§Ŧ āϏāĻžāĻāĻā§āϞ āĻ
ā§āϝāĻžāĻĄāĻā§āĻā§āύā§āĻ āĻā§āĻŽā§āĻĨā§āϰāĻžāĻĒāĻŋ āύā§āύāĨ¤ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻāĻā§āĻ āϤāĻžāĻāϰ āĻĄāĻŋāĻŽā§āĻŦāĻžāĻŖā§ (eggs) āĻšāĻŋāĻŽāĻžāϝāĻŧāĻŋāϤ āĻŦāĻž āϏāĻāϰāĻā§āώāĻŖ āĻāϰ⧠āϰāĻžāĻāĻž āĻšā§ā§āĻāĻŋāϞāĨ¤ āĻāĻ āĻŦāĻāϰ āĻĒāϰ āϤāĻŋāύāĻŋ āĻĻā§āĻŦāĻžāϰ IVF-āĻāϰ āĻā§āώā§āĻāĻž āĻāϰā§āĻ āϏāĻĢāϞ āĻšāύāύāĻŋāĨ¤ āĻāĻŋāύā§āϤ⧠āĻāĻŽāϰāĻž āĻšāĻžāϞ āĻāĻžā§āĻŋāύāĻŋāĨ¤
⧍ā§Ļ⧍ā§Ģ āϏāĻžāϞā§āϰ āĻļā§āώā§āϰ āĻĻāĻŋāĻā§, āĻāĻŽāĻžāϰ āϤāϤā§āϤā§āĻŦāĻžāĻŦāϧāĻžāύ⧠āϤāĻŋāύāĻŋ āϏā§āĻŦāĻžāĻāĻžāĻŦāĻŋāĻāĻāĻžāĻŦā§āĻ āĻāϰā§āĻāϧāĻžāϰāĻŖ āĻāϰā§āύāĨ¤ ā§Šā§Ž āϏāĻĒā§āϤāĻžāĻš āϧāϰ⧠āϏāϤāϰā§āĻāϤāĻž, āĻāĻĻā§āĻŦā§āĻ āĻ āĻŽā§āĻĻā§ āĻāĻļāĻžāĻŦāĻžāĻĻā§āϰ āĻŽāϧā§āϝ āĻĻāĻŋā§ā§ āĻāϞāĻžāϰ āĻĒāϰ, ⧍ā§Ļ⧍ā§Ŧ āϏāĻžāϞā§āϰ āĻā§āύ āĻŽāĻžāϏ⧠āĻāĻŋāĻā§āĻāĻž āĻāĻāĻŋāϞ āĻ
āϏā§āϤā§āϰā§āĻĒāĻāĻžāϰā§āϰ (LSCS) āĻŽāĻžāϧā§āϝāĻŽā§ āϤāĻŋāύāĻŋ ā§Šā§¨ā§Ļā§Ļ āĻā§āϰāĻžāĻŽ āĻāĻāύā§āϰ āĻāĻ āϏā§āϏā§āĻĨ āĻĒā§āϤā§āϰāϏāύā§āϤāĻžāύā§āϰ āĻāύā§āĻŽ āĻĻā§āύāĨ¤ āĻŽāĻž āĻ āĻļāĻŋāĻļā§ āĻĻā§āĻāύā§āĻ āĻāĻāύ āĻāĻžāϞ⧠āĻāĻā§āύāĨ¤
āĻāĻ āĻāĻāύāĻžāĻāĻŋ āĻĄāĻŋāĻŽā§āĻŦāĻžāĻļā§ā§āϰ āĻā§āϝāĻžāύā§āϏāĻžāϰ⧠āĻāĻā§āϰāĻžāύā§āϤ āύāĻžāϰā§āĻĻā§āϰ āĻāύā§āϝ āĻŦā§āϝāĻā§āϤāĻŋāĻāϤ āĻĒā§āϰā§ā§āĻāύ-āĻŽāĻžāĻĢāĻŋāĻ āĻāĻŋāĻāĻŋā§āϏāĻž (personalised care), āĻĒā§āϰāĻāύāύ āĻā§āώāĻŽāϤāĻž āϰāĻā§āώāĻžāϰ āϏā§āϝā§āĻ āĻāĻŦāĻ āĻāĻāĻāύ āĻāĻžāĻāύā§āĻā§āϞāĻāĻŋāĻā§āϝāĻžāϞ āĻ
āύāĻā§āϞāĻāĻŋāϏā§āĻā§āϰ āύā§āϤā§āϤā§āĻŦāĻžāϧā§āύ āĻĻāϞā§āϰ āϤāϤā§āϤā§āĻŦāĻžāĻŦāϧāĻžāύ⧠āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻĒā§āϰā§ā§āĻāύā§ā§āϤāĻžāĻā§ āϤā§āϞ⧠āϧāϰā§āĨ¤
āĻāĻŽāĻžāĻĻā§āϰ āϏāĻŽāĻžāĻā§ āϏāĻžāϧāĻžāϰāĻŖāϤ āϧāĻžāϰāĻŖāĻž āĻāϰāĻž āĻšā§ āϝ⧠āĻā§āϝāĻžāύā§āϏāĻžāϰ āϧāϰāĻž āĻĒā§āĻžāϰ āĻ
āϰā§āĻĨāĻ āĻšāϞ⧠āĻā§āĻŦāύā§āϰ āϏāĻŽāĻžāĻĒā§āϤāĻŋ āĻāĻŦāĻ āϏāĻŦ āĻāĻļāĻž āĻā§ā§ā§ āĻĻā§āĻā§āĻžāĨ¤ āĻāĻŋāύā§āϤ⧠āϤāĻžāĻāϰ āĻā§āώā§āϤā§āϰā§, āϏāĻŽā§āĻŽāϤ⧠āϰā§āĻ āύāĻŋāϰā§āĻŖā§, āϏāĻ āĻŋāĻ āϰā§āĻĢāĻžāϰā§āϞ āĻ āĻāĻŋāĻāĻŋā§āϏāĻž āĻā§āϰāĻšāĻŖ āĻāĻŦāĻ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻŽāύā§āϝā§āĻ āĻĻāĻŋā§ā§ āĻŽā§āύ⧠āĻāϞāĻžāϰ āĻĢāϞ⧠āĻā§āϝāĻžāύā§āϏāĻžāϰ āϧāϰāĻž āĻĒā§āĻžāϰ āĻĒāϰā§āĻ āϝā§āύ āϤāĻžāĻāϰ āĻāĻ āύāϤā§āύ āĻā§āĻŦāύā§āϰ āϏā§āĻāύāĻž āĻšāϞā§āĨ¤